NURS 6011 PHARM FINALS review updated (2019/2020) – Herzing University

NURS 6011 PHARM FINALS review updated (2019/2020) – Herzing University 1.The nurse provides teaching for a patient who will begin taking bosentan [Tracleer] for pulmonary arterial hypertension (PAH). Which statement by the patient indicates a need for further teaching about this medication? a. “I may take this medication with or without food.” b. “I may develop irreversible liver damage while taking this drug.” c. “I should not take cyclosporine while taking this medication.” d. “I will need to have lab tests every month while taking this drug.” ANS: B Liver injury may occur with bosentan but all cases to date have been reversible. The medication may be taken without regard to meals. Patients taking bosentan should not take cyclosporine concurrently. Patients will need to have liver enzymes measured monthly while taking the drug. 2. A patient with a history of heart disease develops pulmonary arterial hypertension (PAH), and the provider is considering prescribing sildenafil [Revatio]. The nurse caring for this patient will perform a careful drug history and notify the provider if the patient is taking which medication? a. A beta blocker b. A calcium channel blocker c. Nitroglycerin d. Warfarin ANS: C Patients taking sildenafil should not take nitroglycerin, since the combination can produce a life-threatening drop in blood pressure. Beta blockers, calcium channel blockers, and warfarin are not contraindicated with sildenafil. 3. A pregnant patient begins active labor at 30 weeks’ gestation. The provider orders dexamethasone 6 mg intramuscularly to be given twice daily for 4 doses. The patient asks the nurse what effect this drug will have on the fetus. The nurse will tell her that the dexamethasone is given to: a. improve cognitive function in the fetus. b. improve fetal neuromotor development. c. increase fetal weight and length. d. increase lung development in the fetus. ANS: D When preterm delivery cannot be prevented, injecting the pregnant patient with glucocorticoids can accelerate fetal lung maturation. Glucocorticoids do not improve cognitive function, neuromotor development, or physical size in the fetus.